Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This is a long-term, open-label clinical study designed to enable longer-term treatment of
patients completing other clinical studies with intramuscular olanzapine depot.
Key objectives of the study are to:
- Determine how well intramuscular (IM) olanzapine depot works during long-term treatment,
- Evaluate the safety and tolerability of IM olanzapine depot during long-term treatment,
- Determine the blood levels of IM olanzapine depot in patients during long-term treatment